9:15 AM ET
8-K
Investor Presentation
AIM ImmunoTech Investor Presentation
AIM ImmunoTech Inc. has released a new corporate presentation titled 'The Ampligen Opportunity' along with a corresponding press release. The presentation outlines the company's strategic objectives and the clinical potential of its lead drug candidate, Ampligen, particularly in treating pancreatic cancer.